The FY2025 (Dec) proxy of Siga Technologies names 19 peer companies for pay. Among Siga Technologies and these peers, CEO pay was 8th highest of 10 and total shareholder return was 6th highest of 9.
8th highest of 10in Siga Technologies and its pay peers, FY2025 (Dec) by CEO pay:
$1.7M$7.9M
6th highest of 9in Siga Technologies and its pay peers, FY2025 (Dec) by total shareholder return:
$14$716
Pay peer group, FY2025 (Dec) proxy
| Harmony Biosciences Holdings | ||
| CorMedix | ||
| Emergent BioSolutions | ||
| Rigel Pharmaceuticals | ||
| UroGen Pharma | ||
| Vanda Pharmaceuticals | ||
| Aquestive Therapeutics | ||
| Eton Pharmaceuticals | Not disclosed | |
| Collegium Pharmaceutical | ||
| Akebia Therapeutics | Not disclosed | Not disclosed |
| Esperion Therapeutics, Inc. | Not disclosed | Not disclosed |
| Fennec Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Heron Therapeutics, Inc. | Not disclosed | Not disclosed |
| Innoviva Specialty Therapeutics, Inc. | Not disclosed | Not disclosed |
| Invivyd, Inc. | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Ligand Pharmaceuticals | Not disclosed | Not disclosed |
| Liquidia Technologies Inc. | Not disclosed | Not disclosed |
| Theravance Biopharma, Inc. | Not disclosed | Not disclosed |
19 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.